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The physiological activation of T lymphocytes requires the triggering of the
disulfide-linked, 90-kD a/,0 heterodimer of the T cell receptor after its recogni-
tion of antigen that is displayed on the cell surface of a suitable APC in the
context of either an MHC class I or class II gene product (1, 2) . The T cell
receptor (Ti)' is part ofa molecular complex that contains four distinct, nonco-
valently associated polypeptide chains, some of which are reactive with anti-T3
mAbs in man (3, 4) . An obligatory requirement for coexpression of the Ti and
T3 exists for activation of T lymphocytes (5, 6) . In addition to the T3-Ti
complex, the T 1 1 molecule (7) and the 44-kD polypeptide identified by human
mAb 9 .3 (8, 9), as well as Thy-1 (10-12) and the recently described murine 12-
kD TAP protein (13), have each been implicated in playing a role in the T cell
activation process, since mAbs against all of these structures can be mitogenic .
The putative function of this latter group of cell surface molecules is poorly
understood, although they may function either to amplify or modify signals
generated via the T3-Ti complex, or may serve as distinct alternative pathways
for T cell activation, as has been suggested for T11 (7, 14) .
The development and use of mAbs have permitted the definition of a number
of other cell surface molecules that are expressed on T cells, but in many cases
the potential role of these molecules in T cell function is not known because
these mAbs do not affect T cell functions when added continuously to culture,
and they do not appear to be markers for functional subpopulations of T cells .
In the mouse, one such group of cell surface molecules whose function is not
understood is the Ly-6 alloantigens . The Ly-6 locus is found on murine chro-
mosome 2, and it controls the expression and/or encodes for alloantigenic
specificities found primarily on T and B lymphocytes (15) . Two haplotypes, Ly-
6.1 and Ly-6 .2, map to the Ly-6 locus . As many as five distinct Ly-6 alloantigens
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may exist for each haplotype (16-18), and mAbs are available that are specific
for Ly-6.2A, B, C, and D, and Ly-6.1 E . However, the distinction of Ly-6A-E
specificities largely resides in different cell distributions of the determinants
detected by these mAbs. Detailed biochemical and molecular analyses of Ly-6
molecules and genes are necessary to establish precisely the nature of the
specificities detected by these antibodies, and whether Ly-6 may represent a
multigene complex rather than a single gene (19).
We have recently identified and characterized a new rat mAb, D7, that
recognizes a nonpolymorphic Ly-6 sped ficity. 2 Serological and biochemical stud-
ies indicated that D7 defined a determinant on molecules bearing Ly-6E.1
specificities in Ly-6 .1+ strains, as well as a determinant on molecules bearing Ly-
6A .2 in Ly-6.2+ strains . In the present report, we will show that after crosslinking,
mAb D7 is a potent inducer of T cell activation, as assayed by augmentation of
antigen- and alloantigen-induced T cell proliferation, by induction of IL-2
production by T cell hybridomas, by induction of resting T cell proliferation in
the presence of the costimulator, PMA, and by induction of a rise in cytoplasmic-
free calcium [Ca
2+
Ii . Furthermore, a number of other well-characterized mAbs
to Ly-6 locus products also appear to be capable of inducing T cell activation .
Collectively, these findings raise the possibility that an Ly-6 molecule(s) may play
a critical role in the T cell activation cascade.
Materials and Methods
Animals.
￿
Mice were obtained from the Animal Production Service, National Institutes
of Health .
Antibodies.
￿
Production and characterization of mAb D7 to a nonpolymorphic Ly-6
specificity has been described in detail elsewhere.' The anti-Ly-6 mAbs 34-11-3 (17),
58 .106 (18), and 6C3 (20) have also been previously characterized. mAb 109-9-17, which
is directed to Ly-6C.2, was the generous gift of Dr. J. Bluestone, NIH. The properties of
mAbs H10-13-4 to Thy-1 .2 (21), Gk1 .5 to L3T4 (22), 19/178C to Ly-2 .2 (23), Fd441 .8
to LFA-1 (24), M5/114 (25) to la, 7D4 and 3C7 to the IL-2-R (26, 27), M1/42.3 .9 .8 to
H-2 (28), M1/9.3 .4.HL.2 to the common leukocyte antigen (29), 24G2 to the Fc receptor
(30), and MAR 18.5 to rat is light chains (31) have all been described previously. Rabbit
anti-rat Ig serum (RARIg) was produced by immunizing a rabbit with rat -y-globulin
fraction (Cappell Laboratories, Cochranville, PA). 1 mg of protein was injected subcuta-
neously in CFA, followed by a boost 3 wk later with 0.4 mg injected intramuscularly in
IFA ; after two additional boosts every 60 d the rabbit was bled repeatedly. The RARIg
serum was highly crossreactive with mouse Ig. Goat anti-rat IgG sera were purchased
from Cappel Laboratories.
Purification of D7.
￿
D7 was purified on an immunoaffinity column containing MAR
18 .5. After elution with 3.5M MgCh, the antibodies were extensively dialyzed in 0.01 M
PBS, pH 7.4, and was then filter-sterilized.
CultureMedium.
￿
All cultures were performed in RPMI 1640 (Biofluids Inc., Rockville,
MD) supplemented with glutamine (300 Ag/ml), penicillin (100 U/ml), streptomycin (100
pg/ml), 2-ME (5 X 10-5 M), and 10% FCS.
T Cell Hybridomas.
￿
Antigen-specific T cell hybridomas were produced by fusion of
immune T cells to BW5147, as previously described (32). To induce IL-2 secretion, the
T cell hybridomas (10) were cultured in 0 .2 ml of medium in 96-well microtiter plates
(3596; Costar, Cambridge, MA), with or without the various stimuli, for 24-48 h. The
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IL-2 activity in the culture supernatants was detected by its capacity to stimulate the
proliferation of an IL-2-dependent line, CTL-L.
Cell Purification and Culture Conditions.
￿
T lymphocytes were isolated from spleens,
peripheral lymph nodes, or mesenteric lymph nodes (33) by collection of nylon wool
nonadherent cells. Nonimmune T cells were used in all experiments, except in studies
that measured antigen-specific proliferation, in which case the mice were previously
immunized in the foot pads with 50 jug beef insulin (BINS) emulsified in CFA. AC
depletion of the T cell populations was accomplished by treatment with anti-la antibody
(M5/114) and C (33). Isolation of L3T4+ or Ly-2+ T cells was accomplished by treatment
of the T cells with either anti-Ly-2.2 (19/178C) (23) or anti-L3T4 (Gk1 .5), respectively,
and C as previously described (33). AC were either anti-Thy-1 .2 + C-treated, irradiated
(2,500 rad) spleen cells or irradiated (10,000 rad) LB cells, a B cell hybridoma with
antigen presenting capacity (34). The cells were cultured with the various stimuli in 0.2
ml of medium in 96-well microtiter plates. The exact culture conditions for individual
experiments are described in the legends to the Figures and Tables. Proliferation of the
cultures was measured by adding [6H]TdR (New England Nuclear, Boston, MA) during
the last 16 h of culture, and then harvesting the cells with a semiautomated device (Ph.d,
Cambridge, MA). Data are expressed as the mean of triplicate cultures. The SEM was
generally <10% of the mean .
Determination of /Ca"] ; . In a modification of the method described by Tsien et al.
(35-37), the cells to be assayed (5 X 106/ml) were loaded in complete culture medium
with a final concentration of 15 tM Quin 2-AM (Sigma Chemical Co., St. Louis, MO) for
20 minutes. After loading, the cellswere washed two times with Dulbecco's PBS (Biofluids,
Inc .), resuspended in the same buffer to a concentration of 5 X 106 cells/ml, and were
used innnediately after equilibration at 37°C for 5 min. When indicated, Quin-2-loaded
T cells (107) were incubated with mAb D7 (250 ul of 1 :10 ascites) for 15 min at 37°C,
and were washed again two times. Fluorescence intensity was measured with a Perkin
Elmer fluorescence spectrophotometer LS-5 (excitation, 339 nm ; emission, 492 nm). The
cuvette chamber was maintained at 37'C, and the cell suspension was continuously stirred.
After a baseline was established, goat anti-rat IgG serum (1/100) was added. Maximum
fluorescence (F,;,x) was determined by lysing the Quin-2-loaded cells with 0.1 % Triton X-
100. Minimum fluorescence (F,;) was obtained after addition of EGTA (4 mM) and
sufficient Tris-buffer to raise the pH to 8.0 (to optimize chelation of Ca" by EGTA).
Approximate values for cytoplasmic-free Ca" were calculated by the formula: [Ca"] ; . -
115 nM (F - F,,)/(F~»;,x - F.).
Results
D7 Activates Normal T Cells in the Presence of PMA and AC.
￿
The D7 tnAb
defined a nonpolymorphic specificity that mapped to the Ly-6 locus and reacted
with an epitope on 20-30% of spleen cells from Ly-6.1 mice (e.g., BALB/c), and
on 50-70% of spleen cells from Ly-6.2 mice (e.g., C57BL/6). Mitogen stimulation
of the spleen cells resulted in the expression of high levels of D7 bearing Ly-6
molecules on all activated T and B lymphocytes, regardless of the strain.' When
nylon column-passed, anti-la- and C-treated, lymph node T cells were cultured
with D7 in the presence or absence of PMA (Table 1), we did not see a significant
proliferative response. However, when the cultures were supplemented with T
cell-depleted spleen cells as a source of AC, we saw a vigorous proliferative
response, but only when PMA was present. Thus, the stimulation of resting T
cell proliferation by mAb D7 required two costimulatory signals PMA and AC
function provided by T cell-depleted spleen cells. The stimulatory capacity of
mAb D7 was not restricted to one of the major T cell subsets as both L3T4+
and Ly-2+ T cells showed equivalent proliferative responses when challenged
with D7 and PMA in the presence of AC (Fig. 1).712 T CELL ACTIVATION BY ANTI-LY-6 MONOCLONAL ANTIBODIES
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TABLE I
D7 Activates Peripheral TLymphocytes in the Presence of
PMA andAC
Nylon column-passed mesenteric lymph node cells were treated with anti-
la and C and then cultured (105 cells/well) in the presence or absence of
T cell-depleted spleen cells (105 cells/well) as a source of AC.
[RH]TdR incorporation was determined after 72 h of culture; each value
is the mean of three determinations.
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FIGURE 1 .
￿
Proliferation ofL3T4' and Ly-2' T cells to D7 is AC-dependent. Highly purified
AC-depleted L3T4' (A) or Ly-2' (B) T cells (2 X 105) from BALB/c mice were cultured with
PMA (10 ng/ml), and the indicated concentration of purified D7 in the presence (-) or
absence (---) of normal AC (2 X 105) for 72 h .
The stimulation of purified T cells by the combination of D7, PMA, and AC
resulted in both IL-2 production in the culture supernatants 24 h after culture
initiation, as well as IL-2-R expression, as determined by staining with an mAb
to the IL-2-R (7D4) and analysis by flow cytometry (results not shown). Neither
IL-2 production nor IL-2-R expression was observed unless all three stimulatory
signals were present. The proliferative response seen after 72 h of culture was
readily inhibited by addition of the anti-IL-2-R mAb to the culture (Fig. 2).
Taken together, these results indicate that D7-induced Tcell proliferation occurs
by an IL-2-dependent pathway.
D7 Induces IL-2 Secretion by T Cell Hybridomas.
￿
We have shown elsewhere
that BW5147, as well as several Tcell hybridomas that were generated by fusion
of activated T cells to BW5147, expressed Ly-6 molecules as defined by D7. 2
Stimulus AC
[sH]TdR
Exp. I
incorporation
Exp. 2
Medium - 999 845
+ 1,324 1,222
PMA (10 ng/ml) - 2,545 5,949
+ 3,579 6,577
D7 (10 jug/ml) - 487 1,112
+ 823 1,496
D7 + PMA - 6,747 15,706
+ 129,325 197,033
Con A (5 ug/m1) - 3,259 426
+ 33,940 78,1140
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FIGURE 2.
￿
Effect of anti-IL-2-R antibodies on D7-induced proliferation. BALB/c T cells (2
x 105) were cultured with PMA (10 ng/ml) and the indicated concentration of D7 in the
presence of 1:500 dilution of control ascites (-, 50CI and 49C2) or anti-IL-2-R antibodies
(---, 3C7and 7D4) for 72 h.
TABLE II
D7 Stimulates IL-2 Production by T Cell Hybridomas in the Absence ofPMA but
in the Presence ofAC
T cell hybridomas (105 cells/well) were cultured with D7 or Con A (5 ,tag/ml) in the
presence of irradiated (10,000 rad) LB cells (2.5 x 104/well) or irradiated (2,500 rads)
T cell-depleted spleen cells (105 cells/well). After a 48 h culture, the IL-2 content of
thesupernatants was assayed by culture on theCTL-L cell line.
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Therefore, we wished to test whether mAb D7 would induce IL-2 secretion by
these hybridoma lines (Table II). Since D7 had no effect on the proliferative
response of CTL-L cells in the presence or absence ofadded IL-2, it was possible
to measure IL-2 levels in supernatants that contained D7. D7 induced the
production of significant amounts of IL-2 from all T cell hybridomas tested in
the absence of PMA; no IL-2 secretion occurred when BW5147 was cultured
with D7 (not shown). However, in contrast to the response to the mitogen Con
A, D7-induced IL-2 secretion required that the cultures be supplemented with
LB cells (34) . Under these conditions, the amount of IL-2 that was secreted was
comparable to that induced by Con A. Presumably, the role of LB cells in the
Hybridoma AC
Medium
[5H]TdR of
D7 (1 ag/ml)
CTL-L (cpm)
D7 (10 vg/ml) Con A
6-3 None 3,614 2,431 3,584 12,096
Spleen AC 1,610 1,388 1,613 13,760
LB cells 1,540 14,571 26,514 44,304
4-7 None 2,200 1,759 1,350 38,037
Spleen AC 2,992 1,895 2,055 53,517
LB cells 1,040 47,861 59,380 62,626
4-1 None 6,676 8,462 4,651 33,426
Spleen AC 4,555 867 3,522 30,750
LB cells 1,212 53,776 54,487 61,990
A22 None 837 1,296 1,150 23,023
Spleen AC 848 771 887 24,777
LB cells 3,115 13,048 25,547 51,773714
￿
T CELL ACTIVATION BY ANTI-LY-6 MONOCLONAL ANTIBODIES
TABLE III
AC Functionfor D7 Stimulation Is Fc Receptor-mediated
* The indicated T cell hybridoma (105) was cultured with LB (2.5 x 10' cells/well) and
D7 (10 Wg/ml) or BINS (10 jug/ml), pork insulin (PINS, 10 rug/ml), or OVA (50
mg/ml) in the presence or absence ofthe anti-Fc receptor antibody (24G2, 5% culture
supernatant) for 48 h. The cpm represent IL-2 production as assayed on CTL-L cells.
Nylon column-passed BALB/c T cells (2 x 105) were cultured with PMA (10 ng/ml)
and D7 (10 wg/ml) in the presence or absence ofan anti-Fc receptor antibody (24G2)
for 72 h. Results are expressed as cpm ['H]TdR incorporation.
cultures was to provide an AC function . In view of the ability of anti-Thy-I and
C-treated spleen cells to function as AC for D7-induced proliferation of normal
spleen T cells, it was surprising that such normal AC populations failed to
function with D7 to induce IL-2 secretion by the T cell hybrids. Thus, these
results indicated that the induction of IL-2 secretion by D7 was AC-dependent,
and they suggested that a qualitative or quantitative difference existed in the
capacity ofdifferent cell populations to serve as AC.
Fc-mediated Crosslinking ofD7 Is Required for T Cell Activation.
￿
One possible
role for the AC in D7-mediated T cell activation is that the Fc receptor on the
AC is required for crosslinking of D7 bound to the responder T cell. To directly
test this possibility, we examined whether an mAb (24G2) to the murine Fc
receptor (30) could inhibit D7-induced IL-2 secretion by antigen-specific T cell
hybridomas in the presence of LB cells (Table 111, Exp. 1). In each instance, IL-
2secretion by several T cell hybridomas in response to D7 was markedly inhibited
by 24G2. As an internal specificity control, 24G2 had no inhibitory effects on
antigen-induced IL-2 secretion by these same hybridomas in the presence of LB
cells. 24G2 also inhibited the proliferation of splenic T cells to D7 and PMA
(Table III, Exp. 2). However, 24G2 did not inhibit the background proliferative
response of the T cells to PMA alone, which in this particular experiment was
somewhat higher than usually seen. This result indicated that Fc receptor-
mediated function was also necessary for D7-induced mitogenesis of normal T
cells.
We next evaluated whether crosslinking of D7 bound to the responder cell
surface with anti-Ig could also induce T cell activation in the presence of PMA,
but in the absence ofAC. Highly purified, AC-depleted T cells were pretreated
with D7 or a variety ofother mAbs with different specificities. The Tcells were
then cultured with PMA in the presence or absence of a rabbit anti-rat Ig serum
Exp. Responding cell Stimulus Without
24G2
cpm
With
24G2
1 T cell hybrids*
AF3G7 LB + BINS 20,194 20,266
LB + D7 44,262 <100
P4.4 LB + PINS 89,133 133,778
LB + D7 21,276 1,867
A22 LB + OVA 13,510 20,817
LB + D7 37,687 7,813
2 T cells$ PMA 35,689 27,256
PMA + D7 + AG 165,806 30,682MALEK ET AL.
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TABLE IV
The AC Cell Requirementfor D7 Stimulation Can Be Bypassed by the
Use of a Crosslinking Second Antibody
Highly purified AC-depleted T cells (2 x 105) from BALB/c mice were
pretreated by incubation with an excess of the indicated antibody, were
washed, and then cultured with PMA (10 ng/ml) and 1:500 dilution of
rabbit anti-rat Ig antiserum for 72 h as indicated. Results are expressed
as 0 cpm [sH]TdR incorporation [(cpm ['H]TdR incorporation in the
presence of stimulus) - (cpm in medium alone)]. Background responsesin
thepresence of medium alone were <2,000 cpm.
(Table IV). A significant proliferative response was seen after antibody-induced
crosslinking of D7 in the presence of PMA. This proliferative response was
comparable to the response from cultures that contained AC, continuous D7,
and PMA. In contrast, no proliferation was seen after crosslinking other antibod-
ies reactive with the responding T cells, with the possible exception of a small
degree of proliferation when the cells were pretreated with mAb M1/42.3.9.8
directed to a framework determinant of H-2.
Fffect of D7 on Alloantigen-, Antigen-, and Mitogen-induced T Cell Prolifera-
tion. The addition of purified D7 caused a dose-dependent enhancement of the
MLR (Fig. 3A) and antigen-specific T cell proliferative responses to BINS and
PPD (Fig. 3B) . Although minimal proliferation was noted when T cells were
cultured with syngeneic stimulator cells, the addition of D7 also permitted the
detection of a syngeneic MLR (SMLR) (Fig. 3A). D7 enhanced proliferation in
these assays when T cells from BALB/c and C57BL/6 mice were analyzed,
indicating that T cells from both Ly-6 .1 and Ly-6 .2 mice were affected by D7 .
Dose-response studies showed that as little as 10 ng/ml of D7 was needed to
cause detectable enhancement of proliferation, although maximal responses were
detected at 10 ug/ml ofantibody. Surprisingly, D7 failed to enhance proliferation
when T cells were stimulated with the mitogens Con A and PHA (Fig . 3 C) . This
failure of D7 to augment mitogen-induced proliferation was also seen when a
suboptimal concentration of Con A (Fig. 3C) or PHA (not shown) was used to
stimulate the T cells. We never observed inhibitory effects of D7 on T cell
activation under a variety of culture conditions.
Other Anti-Ly-6 mAbs Induce T Cell Activation.
￿
Although thestudies performed
thus far have all used the anti-Ly-6 mAb, D7, we wished to evaluate other well-
Pretreatment
A cpm ['H]TdR incorporation
PMA PMA + Anti-rat Ig
Medium 2,414 4,261
D7 5,024 341,871
LFA-1 3,704 2,321
H-2 4,014 14,976
CLA 3,453 5,217
la 2,821 2,045
L3T4 2,891 4,588
Ly-2 2,149 4,049
Continuous D7 + PMA, 5,928
Continuous D7 + PMA + AC, 256,550716 T CELL ACTIVATION BY ANTI-LY-6 MONOCLONAL ANTIBODIES
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FIGURE 3 .
￿
Effect of D7 on T lymphocyte proliferation. (A) Effect on the MLR and syngeneic
MLR. Nylon wool-purified T lymphocytes from mesenteric lymph node (2 X 105) were
cultured with syngeneic or allogeneic anti-Thy-1 .2 + C-treated irradiated (2,500 rad) spleen
cells (2 X 105) for 5 d. The cultures were BALB/c anti-BALB/c (0), BALB/c anti-C57BL/6
(p), C57BL/6 anti-C57BL/c (A), and C57BL/6 anti-BALB/c (A). (B) Effect on antigen-induced
proliferation. Nylon wool-purified lymph node Tcells (2 X 105) from BALB/c mice immunized
with BINS were cultured with BINS (10 ag/ml, 9; 50 ttg/ml, p) or PPD (10 ag/ml, A; 50
jag/ml, A) for 5 d. (C) Effect on mitogen-induced T cell proliferation. Nylon wool-purified
splenic T cells (105) from BALB/c mice were cultured with Con A (1 .0 Atg/ml, 0; 5 ag/ml, p)
or PHA (I jug/ml, A) for 72 h. In all experiments D7 was added at culture initiation at the
indicated concentration. ['H]TdR incorporation was measured during the last 16 h of the
culture. Proliferation of unstimulated T cells was always <1,000 cpm.
TABLE V
Induction of TCell Activation by Anti-Ly-6 mAbs
Nylon column-passed, anti-la and C-treated, C57BL/6 T cells (5 X 106) were
incubated with the designated mAb (ascites, 1/200) for 1 h at 4°C, washed, and
then cultured (2 X 105 cells/well) for 72 h in the presence of PMA (10 ng/ml)
and rabbit anti-rat Ig serum (1/1000) for 72 h . Results are expressed as A cpm
['H] TdR incorporation [(cpm in the presence of PMA and anti-Ig) - (cpm in
the presence of PMA alone)]. The background responses ofT cells that were not
preincubated with an mAb, but were cultured in the presence of PMA and the
anti-Ig serum, were uniformly <4,000 cpm.
characterized anti-Ly-6 rnAbs for their capacity to induce Tcell activation (Table
V). C57BL/6 "f cells were therefore pretreated with a number of different anti-
Ly-6 reagents, washed, and then cultured in the presence of PMA and a
crosslinking anti-Ig reagent. Although differences in the potencies of the differ-
ent mAbs were observed, all could induce significant proliferative responses. In
contrast to the results obtained with D7 where Fc receptor-bearing T cell-
depleted spleen cells could function as effective crosslinkers, proliferative re-
sponses to all the other mAbs in Table V were only observed when anti-Ig
reagents were used as the crosslinker (data not shown).
mAb Specificity
A cpm
Exp. 1
['H]TdR incorporation
Exp. 2 Exp. 3
D7 Ly-6A.2 + E.1 88,366 140,899 88,904
58.106 Ly-6A.2 61,035 160,477 60,259
34-11-3 Ly-6A.2 35,911 93,537 61,037
109-9-17 Ly-6C.2 42,115 ND 25,856
6C3 Ly-6C ND 36,171 15,074
M1/9.3.4 Common leukocyte 3,258 1,576 0MALEK ET AL.
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FIGURE 4.
￿
Tracing [Ca"]; in T cell hybridoma 2B4. The ordinate on the right side of the
panel shows the absolute levels of [Ca2+],. (A) Addition of goat anti-rat IgG. (B) Addition of
goat anti-rat IgG to hybridoma cells that had been preincubated with D7.
mAb D7 Triggers a Rapid Rise in [Ca 21],.
￿
It has been previously shown (5, 37)
that a number of mAbs to both murine and human cell surface antigens that can
induce T cell activation can also induce a rapid rise in [Ca
21], when added to T
cells. Addition of mAb D7 to 2114 hybridoma cells failed to increase [Ca"] ;
(results not shown). However, when the 2114 hybridoma cells were incubated
with mAb D7, washed, and then incubated with a goat anti-rat IgG reagent, we
observed a rapid rise (162%) in [Ca
21], (Fig. 4B); no increase in [Ca
21], was seen
when the hybridoma cells were treated with the anti-Ig reagent alone (Fig. 4A).
In two other experiments ofthis type performed with a second T cell hybridoma,
we observed 123 and 205% rises of [Ca
2+1,.
We have shown in this report that an mAb, D7, which is specific for a
framework determinant on an Ly-6 antigen, could induce T cell activation after
crosslinking by anti-Ig reagents or by Fc receptor-bearing AC. The ability of
mAb D7 to trigger T cell proliferation in resting murine T cells required the
addition of a costimulator, PMA, while D7 could induce IL-2 production from
T cell hybridomas in the absence of a costimulator. In the presence of a
crosslinker and PMA, D7 was equally mitogenic for L3T4+ and Ly-2+ T cells.
Although a subset of B lymphocytes and ^-10% of normal thymocytes2 also
express the Ly-6 molecule defined by mAb D7, we thus far cannot induce
proliferative responses in these cell populations under a variety ofexperimental
conditions (data not shown) . It was somewhat surprising that D7, in the absence
of PMA, could augment antigen- and alloantigen-, but not mitogen-induced T
cell proliferation . One explanation for this result is that the interaction of D7
with Ly-6 caused an increase in IL-2 secretion, resulting in enhanced prolifera-
tion; the capacity of D7 to directly induce IL-2 secretion in T cell hybridomas is
consistent with this interpretation. However, if this explanation accounted for
augmentation ofnormal T cell responses, D7 should have also enhanced mitogen-
induced proliferation, because other studies have shown that the addition of
exogenous IL-2 to cultures of T cells stimulated with Con A or PHA, especially
at suboptimal mitogen concentrations, invariably led to enhanced proliferative
responses (unpublished data). An alternative explanation is that the Ly-6 mole-
cule may function to amplify weak signals transmitted by antigen or alloantigen
triggering of the T3-Ti complex, while mitogen-induced triggering may be
operating optimally through the Ly-6 pathway, thus accounting for the failure71 8
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of D7 to augment initogen-induced proliferative responses. We also cannot
exclude the possibility that T cell stimulation by antigen or alloantigen, but not
mitogen, somehow facilitates the response of nonantigen specific T cells to
stimulation by mAb D7.
The ability to activate T cells via Ly-6 was not a property unique to mAb D7;
several other mAbs to Ly-6 molecules also stimulated proliferation of resting T
cells after crosslinking and in the presence of PMA. It should be emphasized that
mAbs to both Ly-6A.2 and Ly-6C.2 determinants were mitogenic, and that these
mAbs identify determinants with markedly disparate tissue distributions (17, 18).
We have previously shown that the binding of mAb D7 to cells from Ly-6.1+
strains can be completely blocked by mAb HD-42.2 It is noteworthy that Flood
et al. (38) have recently implicated Ly-6 molecules in T cell function by virtue
ofthe ability ofHD-42 to inhibita number ofTcells responses in vitro, including
IL-2-dependent proliferation of mitogen-activated T cells blasts. We have thus
far been unable to repeat the studies of Flood et al. (38) with mAb HD-42 and,
in fact, in preliminary experiments both mAb HD-42 and a second mAb to Ly-
6E.1 . SK70.94, both appear to induce Tcell activation after crosslinking by anti-
Ig and the addition of PMA in a manner identical to that seen with the other
anti-Ly-6 mAbs (Table V). The discrepancies between our results and those of
Flood et al. are presently under study.
There are a number of similarities between the induction of Tcell activation
via Ly-6 and the induction of activation via T3-Ti, T11, and Thy-1. Activation
through all of these cell surface molecules usually results in a rapid rise in
[Ca21],' which is subsequently followed by IL-2-dependent proliferative responses
(5-7, 37). Activation via T3-Ti, Thy-1, and Ly-6 all require crosslinking of the
stimulating mAb after it binds to its target antigen. Although stimulation via
T11 is AC-independent and does not exhibit any obvious requirement for a
second crosslinking antibody (37), activation via T11 requires the simultaneous
presence oftwo mAbs to distinct epitopes on this molecule, which may in concert
lead to aggregation of T1 1 molecules in a manner similar to that achieved by
crosslinking the mAbs to the other cell surface antigens. Despite these similarities
in the requirements for activation by these mAbs there is no obvious biochemical
relationship between the 14-18 kD molecules recognized by anti-Ly-6 mAbs and
the components of the T3-Ti complex, TI I or Thy-1.
Rock et al. (13) have recently identified an mAb to a novel 10-12 kD T cell
membrane antigen, TAP, which in soluble form will induce IL-2 production
from Tcell hybridomas and induce proliferation ofnormal Tcells in thepresence
ofAC or purified IL-1 . Anti-TAP mAbs in suboptimal concentration could also
augment antigen-specific T cell proliferation. The antigen identified by anti-
TAP, a 10-12 kD band on SDS-PAGE under nonreducing conditions, appears
to be distinct from the 14-18 kD antigen identified by most anti-Ly-6 mAbs,
including D7 (19, 39).2 However, TAP and Ly-6 determinants were coexpressed
on all cell types examined, TAP expression mapped to the Ly-6 locus (39), and
the binding of anti-TAP could be blocked by an anti-Ly-6 mAb (13). One
intriguing possibility is that TAP and Ly-6 are associated with each other in a
complex similar to that described for T3. Thus, mAbs directed to differentMALEK ET AL.
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components of the complex may have different requirements for triggering or
even inhibiting the T cell activation cascade.
The physiological role of the Ly-6 molecule in T cell activation has not been
established in this study. Activation via Ly-6 might be postulated to occur by
either of two general models. In one, Ly-6 would function as a receptor for a
ligand that activates Tcells upon binding Ly-6. In such a model, anti-Ly-6 mAbs
would serve to mimic the physiological action of such a ligand . This would be
analogous to the situation where anti-Ig, or anti-T cell receptor antibodies, or
some anti-hormone receptor antibodies activate cellular responses. The ligand
for Ly-6 might be a lymphokine or a distinct cell surface antigen, perhaps
expressed on the cell surface of an APC. In this model, Ly-6 may function as an
alternative pathway for activation of murine T cells in a manner similar to that
suggested for T11 (7, 14). In a second model, Ly-6 could function solely as a
signal-transducing molecule with no external ligand. Ly-6 might then stabilize,
amplify, or transduce signals originally initiated by antigen-stimulation of the
T3-Ti complex. Ly-6 could activate T cell function either alone or as a member
of a larger molecular complex. In view of the general difficulty we and others
have noted in radiolabeling and immunoprecipitating Ly-6 molecules (17, 19), it
is even possible that it could be found in association with the T3-Ti complex or
Thy-1 . Future study is necessary to resolve these issues.
Summary
The Ly-6 locus controls the expression and/or encodes for alloantigenic
specificities found primarily on subpopulations of murine T and B lymphocytes.
We have recently identifiedandcharacterizeda new rat mAb, D7, that recognizes
a nonpolymorphic Ly-6 specificity. After crosslinking by anti-Ig reagents or by
Fc receptor-bearing accessory cells, mAb D7 could induce IL-2 production from
T cell hybridomas, and in the presence of PMA could trigger a vigorous
proliferative response in resting peripheral T cells. The addition of mAb D7 to
cultures ofantigen- and alloantigen-, but not mitogen-stimulated T cells resulted
in a marked augmentation ofthe proliferative response. A number ofother well-
characterized mAbs to Ly-6 locus products could also stimulate a T cell prolif-
erative response after crosslinking by anti-Igand in the presence ofPMA. These
results strongly suggest that Ly-6 molecules may play a critical role in the T cell
activation cascade, either as receptors for an unidentified soluble or cell-associ-
ated ligand or as transducing molecules that modulate signals initiatedbyantigen
stimulation of the T3-Ti complex.
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